Total Payments
$25,230
2024 Payments
$5,122
Companies
17
Transactions
56
Medicare Patients
1,099
Medicare Billing
$129,485
Payment Breakdown by Category
Other$19,037 (75.5%)
Food & Beverage$2,459 (9.7%)
Consulting$2,363 (9.4%)
Travel$884.18 (3.5%)
Research$352.00 (1.4%)
Education$135.40 (0.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Honoraria | $18,525 | 4 | 73.4% |
| Food and Beverage | $2,459 | 41 | 9.7% |
| Consulting Fee | $2,363 | 2 | 9.4% |
| Travel and Lodging | $884.18 | 3 | 3.5% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $500.00 | 1 | 2.0% |
| Unspecified | $352.00 | 1 | 1.4% |
| Education | $135.40 | 3 | 0.5% |
| Grant | $12.00 | 1 | 0.0% |
Payments by Type
General
$24,878
55 transactions
Research
$352.00
1 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| UROGEN PHARMA, INC. | $23,218 | 26 | $0 (2024) |
| Intuitive Surgical, Inc. | $577.12 | 3 | $0 (2023) |
| Dendreon Pharmaceuticals LLC | $381.33 | 5 | $0 (2024) |
| Astellas Pharma US Inc | $214.49 | 3 | $0 (2019) |
| QED Therapeutics, Inc. | $134.91 | 1 | $0 (2021) |
| Myovant Sciences GmbH | $125.00 | 1 | $0 (2021) |
| Merck Sharp & Dohme LLC | $113.38 | 3 | $0 (2023) |
| Janssen Research & Development, LLC | $100.00 | 2 | $0 (2022) |
| Olympus America Inc. | $65.91 | 1 | $0 (2018) |
| Bayer HealthCare Pharmaceuticals Inc. | $56.89 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $5,122 | 8 | UROGEN PHARMA, INC. ($4,940) |
| 2023 | $441.90 | 8 | Dendreon Pharmaceuticals LLC ($199.84) |
| 2022 | $675.39 | 15 | UroGen Pharma, Inc. ($363.93) |
| 2021 | $16,207 | 16 | UROGEN PHARMA, INC. ($15,831) |
| 2020 | $1,952 | 2 | UROGEN PHARMA, INC. ($1,952) |
| 2019 | $675.37 | 5 | Intuitive Surgical, Inc. ($538.87) |
| 2018 | $65.91 | 1 | Olympus America Inc. ($65.91) |
| 2017 | $89.99 | 1 | Astellas Pharma US Inc ($89.99) |
All Payment Transactions
56 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/22/2024 | UROGEN PHARMA, INC. | — | Consulting Fee | Cash or cash equivalent | $1,562.50 | General |
| 10/29/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $145.34 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 08/15/2024 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $106.21 | General |
| Category: UROTHELIAL CANCER | ||||||
| 07/07/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $12.50 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 05/03/2024 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Honoraria | Cash or cash equivalent | $3,125.00 | General |
| Category: UROTHELIAL CANCER | ||||||
| 05/03/2024 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: UROTHELIAL CANCER | ||||||
| 05/03/2024 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $21.71 | General |
| Category: UROTHELIAL CANCER | ||||||
| 01/13/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $23.65 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 12/01/2023 | PFIZER INC. | XTANDI (Drug) | Education | In-kind items and services | $39.99 | General |
| Category: ONCOLOGY | ||||||
| 11/27/2023 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $100.00 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 11/21/2023 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), LYNPARZA | Food and Beverage | In-kind items and services | $17.48 | General |
| Category: ONCOLOGY | ||||||
| 10/01/2023 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $99.84 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 04/12/2023 | UroGen Pharma, Inc. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $125.53 | General |
| Category: UROTHELIAL CANCER | ||||||
| 04/12/2023 | UroGen Pharma, Inc. | JELMYTO (Drug) | Education | In-kind items and services | $5.42 | General |
| Category: UROTHELIAL CANCER | ||||||
| 03/21/2023 | Intuitive Surgical, Inc. | Da Vinci Surgical System (Device) | Food and Beverage | In-kind items and services | $38.25 | General |
| Category: SURGERY | ||||||
| 01/17/2023 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), WELIREG, LYNPARZA | Food and Beverage | In-kind items and services | $15.39 | General |
| Category: ONCOLOGY | ||||||
| 10/03/2022 | UroGen Pharma, Inc. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $104.40 | General |
| Category: UROTHELIAL CANCER | ||||||
| 09/15/2022 | Bayer HealthCare Pharmaceuticals Inc. | Nubeqa (Drug) | Food and Beverage | In-kind items and services | $56.89 | General |
| Category: Oncology | ||||||
| 08/24/2022 | ABBVIE INC. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $13.86 | General |
| Category: ENDOCRINOLOGY | ||||||
| 06/28/2022 | ABBVIE INC. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $13.76 | General |
| Category: ENDOCRINOLOGY | ||||||
| 06/01/2022 | Palette Life Sciences, Inc. | — | Food and Beverage | In-kind items and services | $19.90 | General |
| 05/15/2022 | Antares Pharma, Inc. | NOCDURNA (Drug) | Food and Beverage | In-kind items and services | $43.78 | General |
| Category: NOCTURIA DUE TO NOCTURNAL POLYURIA IN ADULTS | ||||||
| 05/14/2022 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $37.34 | General |
| Category: Oncology | ||||||
| 05/13/2022 | UroGen Pharma, Inc. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $149.80 | General |
| Category: UROTHELIAL CANCER | ||||||
| 04/26/2022 | ABBVIE INC. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $12.17 | General |
| Category: ENDOCRINOLOGY | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| OLYMPUS FINAL MANUSCRIPT | UROGEN PHARMA, INC. | $352.00 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 339 | 423 | $133,470 | $36,900 |
| 2022 | 7 | 249 | 315 | $108,915 | $30,778 |
| 2021 | 8 | 244 | 303 | $111,630 | $33,492 |
| 2020 | 9 | 267 | 343 | $101,562 | $28,315 |
Total Patients
1,099
Total Services
1,384
Medicare Billing
$129,485
Procedure Codes
36
All Medicare Procedures & Services
36 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 38 | 51 | $33,915 | $9,006 | 26.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 74 | 93 | $29,760 | $8,608 | 28.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 35 | 40 | $17,000 | $5,664 | 33.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 34 | 34 | $20,570 | $5,419 | 26.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 46 | 55 | $11,825 | $3,628 | 30.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 11 | 11 | $5,335 | $1,503 | 28.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 25 | 28 | $6,020 | $1,498 | 24.9% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 11 | 11 | $3,245 | $739.97 | 22.8% |
| 74420 | Imaging of urinary tract following injection of a contrast agent | Facility | 2023 | 11 | 25 | $1,675 | $493.97 | 29.5% |
| 81002 | Urinalysis, manual test | Office | 2023 | 38 | 57 | $1,425 | $194.37 | 13.6% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 16 | 18 | $2,700 | $146.08 | 5.4% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2022 | 32 | 50 | $33,250 | $9,189 | 27.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 56 | 70 | $22,400 | $6,340 | 28.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 33 | 33 | $19,965 | $5,664 | 28.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 25 | 33 | $14,025 | $4,178 | 29.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 39 | 46 | $9,890 | $3,081 | 31.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 19 | 20 | $4,300 | $1,090 | 25.3% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 13 | 13 | $3,835 | $1,065 | 27.8% |
| 81002 | Urinalysis, manual test | Office | 2022 | 32 | 50 | $1,250 | $171.21 | 13.7% |
| 52000 | Diagnostic examination of the bladder and bladder canal (urethra) using an endoscope | Office | 2021 | 29 | 45 | $29,925 | $8,362 | 27.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 59 | 71 | $22,720 | $6,825 | 30.0% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 35 | 35 | $21,175 | $6,317 | 29.8% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 30 | 36 | $15,300 | $5,409 | 35.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 43 | 49 | $10,535 | $3,507 | 33.3% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 13 | 13 | $6,305 | $1,587 | 25.2% |
About Dr. Brian Hu, MD
Dr. Brian Hu, MD is a Urology healthcare provider based in Loma Linda, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/20/2008. The National Provider Identifier (NPI) number assigned to this provider is 1003073883.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Brian Hu, MD has received a total of $25,230 in payments from pharmaceutical and medical device companies, with $5,122 received in 2024. These payments were reported across 56 transactions from 17 companies. The most common payment nature is "Honoraria" ($18,525).
As a Medicare-enrolled provider, Hu has provided services to 1,099 Medicare beneficiaries, totaling 1,384 services with total Medicare billing of $129,485. Data is available for 4 years (2020–2023), covering 36 distinct procedure/service records.
Ad
Practice Information
- Specialty Urology
- Location Loma Linda, CA
- Active Since 05/20/2008
- Last Updated 04/10/2018
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1003073883
Products in Payments
- JELMYTO (Drug) $21,560
- Da Vinci Surgical System (Device) $577.12
- PROVENGE (Drug) $381.33
- ORGOVYX (Drug) $125.00
- XTANDI (Drug) $118.42
- WELIREG (Drug) $80.51
- ShockPulse - SE (Device) $65.91
- Nubeqa (Drug) $56.89
- LUPRON DEPOT (Drug) $53.55
- NOCDURNA (Drug) $43.78
- OPDIVO (Biological) $37.34
- Cook (Device) $35.86
- KEYTRUDA (Biological) $32.87
- GENERAL BPH (Device) $12.00
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Loma Linda
Dalton Baldwin, M.d, M.D
Urology — Payments: $64,592
Urology $64,592
Mr. Forrest Jellison, M.d, M.D
Urology — Payments: $5,298
Urology $5,298
Dr. David Benjamin, M.d, M.D
Urology — Payments: $3,664
Urology $3,664
Herbert Ruckle, M.d, M.D
Urology — Payments: $2,579
Urology $2,579
Edmund Ko, M.d, M.D
Urology — Payments: $1,212
Urology $1,212
Dr. Tekisha Lindler, Md, MD
Urology — Payments: $1,153
Urology $1,153